News
Dear readers/followers, You may recall some previous coverage of a Belgian company (currently the only Belgian company I own), with the name of Etablissementen...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Operator Greetings, and welcome to Ark Restaurants Fourth Quarter and Year-End 2025 Results Call. [Operator Instructions]. As a reminder, this conference is being recorded....
News
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
News
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
News
The numbers: Mortgage rates rose for the third week in a row to their highest level since October 2022, as the U.S. economy shows...
News
“A shoe is just a shoe until someone steps into it…” – Deloris Jordan., Michael Jordan’s mom. Air: Courting a Legend. Spring 2023. That...
News
With rising real estate costs, it seems impossible for a lot of people to get ahold of some real estate. With limited supply across...
News
Pros Cons What’s new? The sporty and stylish 2024 Kia K5 is a practical midsize sedan with an outstanding warranty and an exciting GT...
News
Introduction Aya Gold & Silver (OTCQX:AYASF) is small silver producer in Morocco. However, they are ramping up production to become a mid-tier producer. Plus,...
News
This is reprinted by permission from . Travelers are flocking away from overcrowded airport terminals and into airport lounges. And so, these lounges have a...
News
Editor’s note: Seeking Alpha is proud to welcome Gems Capital as a new contributor. It’s easy to become a Seeking Alpha contributor and earn...
News
Gold ends July higher; we believe free cash flow generation, not earnings, is a better way to assess the value and investment appeal of...
News
I have previously discussed, in relation to Eli Lilly (LLY), my expectation that the GLP-1 drug class should readily exceed $100 billion in revenues...
